BlueRock Therapeutics, created in 2016 (Canada), from 2081 sister brands and 17477 competing brands. The BlueRock Therapeutics brand is owned by BAYER, a company listed in Francfort. The ISIN, the company's International Securities Identification Number, is DE000BAY0017. The sector of BlueRock Therapeutics is Drug Manufacturers.
Investment simulator :
Portfolio valuation
BAYER
(BlueRock Therapeutics)
over 5 years*
EUR 14.04